by on May 12, 2026
Celecoxib, a prominent member of the nonsteroidal anti-inflammatory drug (NSAID) class, represents a significant advancement in pain management and anti-inflammatory therapy. Marketed under the brand name Celebrex among others, it was first approved by the U.S. Food and Drug Administration (FDA) in 1998. Its development was driven by the quest to create an NSAID that could provide the analgesic and anti-inflammatory benefits of traditional drugs like ibuprofen and naproxen, while minimizing the ...
6 views 0 likes